does blue cross cover glp-1 MCT2D Results of two-year study show

Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications used primarily for type 2 diabetes management and, in some formulations, for chronic weight management

10 mg or 15 mg of tirzepatide) and continues weekly injections indefinitely

Access to medication is only one part of the equation, weight management today is often difficult to navigate, with patients managing multiple steps across care, medication and lifestyle changes

Journal of Diabetes & Metabolic Disorders

However, Sarwer said that others report increased libido due to the confidence boost, better metabolic health and improved mobility that comes from weight loss (about 18% of people in the above survey reported increased libido and about 16% noted increased sexual satisfaction)

Amylin analogs may modestly boost weight loss and preserve muscle, addressing unmet needs that GLP-1 alone doesnt fully cover